Other likely symptoms include convulsions, neuromuscular symptoms, shock, loss of consciousness, hypotension, ataxia, excessive salivation, limb paralysis, nausea and vomiting, fever, and severe abdominal pain.
This phenomenon is frequently associated with other unilateral conditions such as hemispatial neglect, metamorphognosia, hemiplegia, hemisomatognosia, kinesthetic hallucination, anosognosia, balint optic ataxia, anaesthoagnosia and apraxia.
The movement disorders associated with ataxia can be managed by pharmacological treatments and through physical therapy and occupational therapy to reduce disability.
When given in large doses to laboratory animals, benzyl benzoate can cause hyperexcitation, incoordination, ataxia, convulsions, and respiratory paralysis.
If narrowing of the cerebral aqueduct occurs, many neurological symptoms may exist, including headaches, vertigo, nausea, muscle fasciculations, eye sensitivity, and ataxia.